Randomized phase 2 study to assess safety and efficacy of low-dose (ld) oral decitabine/cedazuridine (astx727) in lower-risk myelodysplastic syndromes (lr-mds) patients: interim safety analysisG. Garcia-Manero,K. Bachiashvili,E. Griffiths,E. Traer,L. Saini,H. Amin,A. Zeidan,S. Mohan,M. Lubbert, L. Maness,J. Foran,D. Selleslag,B. Xicoy,D. Pollyea,D. Sallman,A. Al-Kali,J. Berdeja,H. Al-Ali,N. Zhu,P. Font Lopez,G. Sanz,V. Santini,H. Yimer,L. Cripe,V. Priego,O. Odenike,B. Heyrman,D. Valcarcel,P. Vachhani,Y. Sano,B. Mirakhur,A. Oganesian,H. Keer,A. YacoubLEUKEMIA RESEARCH（2023）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
